AUDUBON, Pa., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended June 30, 2025. Worldwide net sales were $745.3 million, an increase of 18.4$202.8 millionGAAP diluted earnings per share (“EPS”) was $1.49 and non-GAAP diluted EPS was$0.86 “Q2 results were led by our US Spine business, growing 5.7% ...